Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
|---|---|---|---|---|
| Total revenue | 6.09%241.66M | 34.82%227.78M | 21.01%168.95M | 139.62M |
| Operating revenue | 6.09%241.66M | 34.82%227.78M | 21.01%168.95M | --139.62M |
| Cost of revenue | -26.03%104.83M | 30.35%141.71M | 9.08%108.71M | 99.66M |
| Gross profit | 58.98%136.83M | 42.87%86.07M | 50.76%60.24M | 39.96M |
| Operating expense | 6.14%73.27M | 14.00%69.03M | 13.69%60.56M | 53.27M |
| Selling and administrative expenses | 9.27%46.88M | 2.35%42.9M | 19.40%41.91M | --35.1M |
| -Selling and marketing expense | 3.09%21.73M | -0.46%21.08M | 18.84%21.18M | --17.82M |
| -General and administrative expense | 15.25%25.14M | 5.23%21.82M | 19.98%20.73M | --17.28M |
| Depreciation amortization depletion | 7.56%24.92M | 28.12%23.17M | 2.30%18.09M | --17.68M |
| -Depreciation and amortization | 7.56%24.92M | 28.12%23.17M | 2.30%18.09M | --17.68M |
| Other operating expenses | -50.37%1.47M | 429.29%2.96M | 14.99%560K | --487K |
| Operating profit | 273.08%63.57M | 5,508.89%17.04M | 97.63%-315K | -13.31M |
| Net non-operating interest income (expenses) | -34.81%-15.1M | -39.77%-11.2M | -77.83%-8.01M | -4.51M |
| Non-operating interest income | -26.17%443K | 53.06%600K | 1.03%392K | --388K |
| Non-operating interest expense | 30.16%15.32M | 41.34%11.77M | 78.08%8.33M | --4.68M |
| Total other finance cost | 619.35%223K | -60.26%31K | -64.22%78K | --218K |
| Other net income (expenses) | 1.59%2.74M | -40.70%2.7M | 71.29%4.55M | 2.66M |
| Other non-operating income (expenses) | 1.59%2.74M | -40.70%2.7M | 71.29%4.55M | --2.66M |
| Income before tax | 140.10%76.13M | 121.58%31.71M | 467.18%14.31M | 2.52M |
| Income tax | 101.12%26.5M | 99.91%13.18M | 104.75%6.59M | 3.22M |
| Earnings from equity interest net of tax | ||||
| Net income | 167.82%49.63M | 140.08%18.53M | 1,209.05%7.72M | -696K |
| Net income continuous operations | 167.82%49.63M | 140.08%18.53M | 1,209.05%7.72M | ---696K |
| Noncontrolling interests | ||||
| Net income attributable to the company | 167.82%49.63M | 140.08%18.53M | 1,209.05%7.72M | -696K |
| Preferred stock dividends | ||||
| Other under preferred stock dividend | ||||
| Net income attributable to common stockholders | 167.82%49.63M | 140.08%18.53M | 1,209.05%7.72M | -696K |
| Diluted earnings per share | 166.52%0.1186 | 139.25%0.0445 | 1,194.12%0.0186 | -0.0017 |
| Basic earnings per share | 166.04%0.1136 | 139.89%0.0427 | 1,147.06%0.0178 | -0.0017 |
| Dividend per share | 0.00%0.033 | 0.00%0.033 | 0.00%0.033 | 0.033 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |